Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SonoSite

This article was originally published in The Gray Sheet

Executive Summary

Developer of miniaturized, digital ultrasound imaging devices says it will use proceeds from a planned secondary offering of 2.5 mil. common shares "primarily for operating expenses," including product development, sales and marketing costs. SonoSite, based in Bothell, Washington, was spun off from ATL Ultrasound in April 1998. Underwriters Vector Securities and Prudential Securities hold an overallotment option for up to an additional 375,000 shares

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011481

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel